1/29
08:00 am
envb
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
High
Report
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
1/28
05:00 pm
envb
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
High
Report
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
1/28
08:00 am
envb
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
High
Report
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
1/22
07:02 pm
envb
Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board [Yahoo! Finance]
Low
Report
Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board [Yahoo! Finance]
12/30
08:12 am
envb
Enveric Biosciences announces issuance of U.S. patent [Yahoo! Finance]
Medium
Report
Enveric Biosciences announces issuance of U.S. patent [Yahoo! Finance]
12/29
08:00 am
envb
Enveric Biosciences Announces Patent Issuance
Medium
Report
Enveric Biosciences Announces Patent Issuance
12/12
04:46 pm
envb
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
Low
Report
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
12/11
01:43 pm
envb
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
High
Report
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
12/9
08:00 am
envb
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates
Medium
Report
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates
12/4
08:00 am
envb
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
Medium
Report
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
11/26
08:00 am
envb
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
Low
Report
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
11/14
04:54 pm
envb
Enveric Biosciences GAAP EPS of -$10.81 [Seeking Alpha]
Medium
Report
Enveric Biosciences GAAP EPS of -$10.81 [Seeking Alpha]
11/14
04:26 pm
envb
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results [Yahoo! Finance]
Medium
Report
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results [Yahoo! Finance]
11/14
04:05 pm
envb
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
Medium
Report
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results